Hem

Biomarkers

Alzheimers sjukdom

Lästid: 2 minut(s)

Satellite symposium

Implications of an early diagnosis of Alzheimer’s disease

Early diagnosis of Alzheimer’s disease provides patients and their families with the...

Depression, Alzheimers sjukdom

Lästid: 2 minut(s)

Congress highlights

Memory deficits and β-amyloid prominent in elderly with treatment-resistant depression

Elderly patients with treatment-resistant depression have greater cognitive deficits and more brain...

Lästid: 3 minut(s)

Satellite symposium

Optimizing early treatment central in reducing burden of resistant depression

Treatment-resistant depression is associated with a high disease burden, functional impairment,...

Lästid: 3 minut(s)

Congress highlights

From diagnostic categories to underlying dysfunction

Can one-size-fits-all diagnoses be replaced by a symptom-based approach which acknowledges the...

Lästid: 3 minut(s)

Congress highlights

What causes the different phases of migraine?

Migraine is a complex neurological disorder characterized by a prodromal phase, aura, headache,...

Alzheimers sjukdom

Lästid: 2 minut(s)

Congress highlights

Guidance needed on biomarker counseling

Clinicians value biomarkers when assessing mild cognitive impairment but are less certain about how...

Alzheimers sjukdom

Lästid: 3 minut(s)

Congress highlights

Imaging advances diagnosis and staging in dementias

Tau-PET imaging in the clinic is on the horizon and would complement amyloid-PET and structural and...

Lästid: 2 minut(s)

Congress highlights

Can inflammatory biomarkers help to personalize depression treatment?

Which treatment is best suited for which type of depression? Patients with a subtype of major...

Depression, Bipolär sjukdom

Lästid: 3 minut(s)

Congress highlights

In search of biomarkers for mood disorders

Novel biomarkers for mood disorders will enable early diagnosis and inform the development of new...

Lästid: 3 minut(s)

Congress highlights

What is the role of inflammation in the pathophysiology of mood disorders?

Evidence supporting a role for inflammation and pro-inflammatory mediators in the pathophysiology...

Country selection

We are registering that you are located in Brazil - if that's correct then please continue to Progress in Mind Brazil

Not located in Brazil?
Go to a different regional HUB

Continue to Progress in Mind Continue to Progress in Mind Brazil Continue to Progress in Mind MENA Continue to Progress in Mind Spain Continue to Progress in Mind Italy Continue to Progress in Mind Greece Continue to Progress in Mind South East Asia Continue to Progress in Mind Middle East & Africa Continue to Progress in Mind United Kingdom Continue to Progress in Mind Sweden Continue to Progress in Mind Norge Continue to Progress in Mind Denmark Continue to Progress in Mind Finland Continue to Progress in Mind Japan RC Continue to Progress in Mind България Continue to Progress in Mind Israel Continue to Progress in Mind Sweden Continue to Progress in Mind Finland Continue to Progress in Mind Ukraine Continue to Progress in Mind Belgium & Luxembourg Continue to Progress in Mind Switzerland Continue to Progress in Mind Germany Continue to Progress in Mind Austria

Du lämnar Progress in Mind Sverige

Cancel

Du lämnar Progress in Mind Sverige

Progress in Mind Sverige
Registera för nyhetsbrev här

För att få tillgång, var god ange detaljer för att verifiera att du är sjukvårdspersonal.

Om du inte bor i Sverige klicka här

Logga in Registrera dig

Login as a registered health care professional

Vänligen ange din e-post för att fortsätta

Registrera dig som sjukvårdspersonal

Vänligen ange din e-post för att fortsätta

Hello
Please confirm your email

We have just sent you an email, with a confirmation link.
Before you can gain full access - you need to confirm your email.

Den här informationen är endast avsedd för hälso- och sjukvårdspersonal

Acceptera

Neka